Product Highlight Announcement
The 25-OH Vitamin D total ELISA (EIA-5396) was recently awarded the 2015-2016 Certificate of Proficiency by the Vitamin D External Quality Assessment Scheme (DEQAS) Advisory Panel. This designation certifies that the DRG ELISA meets the performance target set by DEQAS for 25 Hydroxyvitamin D.
DRG is committed to bringing to market the best, most accurate tests, and as such, we would like to present the specifications and indications of our 25-OH Vitamin D total ELISA (EIA-5396) testing kit.
Vitamin D deficiency is a serious issue that can affect people at any age. Without enough sunlight and dietary Vitamin D, children may be at greater risk for rickets and adults may be at greater risk for osteoporosis. While issues in bone development and strength are what first come to mind with Vitamin D deficiency, it has been shown that it may raise the risk of high blood pressure and type 2 diabetes.
Beyond the most commonly studied effects of Vitamin D deficiency, there are a wide-range of other health issues that are currently being researched as being directly impacted by Vitamin D deficiency and lack of absorption, including:
- Some types of cancer
- Hypertension (high blood pressure)
- Autoimmune conditions (such as lupus, ankylosing spondylitis, multiple sclerosis, rheumatoid arthritis)
- PCOS (polycystic ovarian syndrome)
- Diabetes mellitus (both types 1 and 2)
DRG offers the 25-OH Vitamin D total ELISA (EIA-5396), approved for laboratory research use only in the United States, and is not for use in diagnostic or therapeutic procedures. However, this product has received its CE Mark.
This DRG Elisa is an enzyme immunoassay for measurement of total 25-OH Vitamin D (Vitamin D2 and Vitamin D3) in serum and plasma.
Specifications of the product include:
- Serum/ Plasma testing
- Only 25 uL sample required
- Kit-internal controls
- Wells single-breakable
- Very simple assay procedure
- 105 min incubation time
- No extraction step required
Latest posts by Gregory C. Guest (see all)
- DRG Launches New Ecommerce Site in May 2017! - May 9, 2017
- DRG Debuts Calprotectin Poster at MEDLAB Asia Pacific 2017! - April 21, 2017
- DRG CA 72-4 ELISA Kit Used in Winthrop University Study - March 15, 2017
News and Updates
DRG International, inc. recently launched our brand new Ecommerce site for USA customers! Click here to shop over 180 ELISA, Salivary ELISA, and CHROMagar products now: https://store.drg-international.com/ The Ecommerce store has over 180 products that are FDA...read more
DRG Booth with Visitors. From Left: Mr. Gideon Lim; Dr. Cyril E. Geacintov, CEO & Founder of DRG; Dr.Aw Tar Choon, MD at Changi General Hospital in Singapore; Mrs. Josephine Teo; Mrs. Elke Geacintov; Mr. Wilhelm Sanger. We are pleased to announce that the DRG...read more
DRG’s CA 72-4 ELISA Kit (EIA-5071), which uses antibodies licensed from the NIH, has been used in a recent study conducted by Winthrop University. The study used the DRG CA 72-4 ELISA Kit (EIA-5071) to explore the expression of CA72-4 compared to current FDA-approved...read more
DRG is pleased to officially announce that we are going to Medlab Dubai from February 6th-February 9th, 2017 at the Dubai International Convention & Exhibition Centre, attended by over 10,000 delegates. The conference features 11 CME-accredited conference...read more
We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting and asked them questions about what makes them the worldwide leader in diagnostics. These are the key takeaways the top executives at DRG want you to remember. Michael Martini (full...read more
DRG’s staff is diverse and the company maintains a global presence requiring its staff to speak multiple languages as well as travel the world visiting DRG’s many offices and events. We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting...read more
We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting and asked them each about what DRG’s strengths are and how they add value to customers and business partners. Wilhelm Saenger (full profile) Our flexibility, flexibility and...read more
As a worldwide leader in diagnostics with several locations spanning the globe, DRG is proud to have a diverse, multilingual staff. We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting and asked each of them about the languages they...read more
Maximilian Saenger, son of the General Manager of DRG Germany (Wilhelm Saenger), traveled to Bishkek, capital of Kyrgyz Republic, during his summer vacation in August 2016.read more
We sat down with top members of the DRG International team at the AACC Convention 2016 in Philadelphia, PA, US and discuss innovation in the diagnostic testing field.read more
Chromogenics was first introduced to the public with the invention and patent for detecting E. coli bacteria by method of “chromogenic differentiation” culture media.read more
The DRG:HYBRID-XL fully automated random access analyzer is the perfect fit for medium or small laboratories. Its compact size can deliver to large demand and can be your primary machine to provide diagnostics to clients.read more